Glycemic variability on continuous glucose monitoring system correlates with non-culprit vessel coronary plaque vulnerability in patients with first-episode acute coronary syndrome – Optical coherence tomography study

Circulation Journal

Volumn 80, Issue 1, 2015, Pages 202-210

  Gohbara, Masaomi ^a   Hibi, Kiyoshi ^a   Mitsuhashi, Takayuki ^a   Maejima, Nobuhiko ^a   Iwahashi, Noriaki ^a   Kataoka, Shunsuke ^a   Akiyama, Eiichi ^a   Tsukahara, Kengo ^a   Kosuge, Masami ^a   Ebina, Toshiaki ^a   Umemura, Satoshi ^b   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Continuous glucose monitoring system; Glucose; Glycemic variability; Optical coherence tomography

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ANGIOGRAPHY; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; ORAL GLUCOSE TOLERANCE TEST; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; HEART INFARCTION; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; ADULT; CORONARY ARTERY OBSTRUCTION; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HOMEOSTASIS MODEL ASSESSMENT; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; NUTRITIONAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TROPONIN I;

EID: 84951770216     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0790     Document Type: Article

References (39)

1. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: Results from the Baltimore Longitudinal Study on Aging. Diabetes 2004; 53: 2095–2100.
2. Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005; 28: 1182–1186.
3. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788–1794.
4. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation 2005; 111: 754–760.
5. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: Implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078–3086.
6. Yang SW, Zhou YJ, Hu DY, Nie XM, Liu YY, Hua Q, et al. Association between admission hypoglycaemia and in-hospital and 3-year mortality in older patients with acute myocardial infarction. Heart 2010; 96: 1444–1450.
7. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segmentelevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124: 704–711.
8. D’Archangelo MJ. New guideline supports the development and evaluation of continuous interstitial glucose monitoring devices. J Diabetes Sci Technol 2008; 2: 332–334.
9. Su G, Mi SH, Li Z, Tao H, Yang HX, Zheng H. Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction. Cardiovasc Diabetol 2013; 12: 33.
10. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Orii M, Shiono Y, et al. Impact of glucose fluctuation and monocyte subsets on coronary plaque rupture. Nutr Metab Cardiovasc Dis 2014; 24: 309–314.
11. JCS Joint Working Group. Guidelines for secondary prevention of myocardial infarction (JCS 2011): Digest version. Circ J 2013; 77: 231–248.
12. Kume T, Okura H, Yamada R, Kawamoto T, Watanabe N, Neishi Y, et al. Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: An ex vivo validation and an initial in vivo feasibility study. Circ J 2009; 73: 1086–1091.
13. Yonetsu T, Bouma BE, Kato K, Fujimoto JG, Jang IK. Optical coherence tomography: 15 years in cardiology. Circ J 2013; 77: 1933–1940.
14. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020–2035.
15. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140–2144.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36: S67–S74.
17. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644–655.
18. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012; 59: 1058–1072.
19. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003; 107: 113–119.
20. Maejima N, Hibi K, Saka K, Nakayama N, Matsuzawa Y, Endo M, et al. Morphological features of non-culprit plaques on optical coherence tomography and integrated backscatter intravascular ultrasound in patients with acute coronary syndromes. Eur Heart J Cardiovasc Imaging 2015; 16: 190–197.
21. Iguchi T, Hasegawa T, Otsuka K, Matsumoto K, Yamazaki T, Nishimura S, et al. Insulin resistance is associated with coronary plaque vulnerability: Insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging 2014; 15: 284–291.
22. Li QX, Fu QQ, Shi SW, Wang YF, Xie JJ, Yu X, et al. Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography. Heart 2010; 96: 196–201.
23. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13–C18.
24. Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP, Valgimigli M, Aoki J, de Feyter P, et al. In vivo intravascular ultra sound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 2005; 46: 2038–2042.
25. Tian J, Dauerman H, Toma C, Samady H, Itoh T, Kuramitsu S, et al. Prevalence and characteristics of TCFA and degree of coronary artery stenosis: An OCT, IVUS, and angiographic study. J Am Coll Cardiol 2014; 64: 672–680.
26. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226–235.
27. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, et al. Coronary plaque regression and lifestyle modification in patients treated with pravastatin: Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol. Circ J 2010; 74: 954–961.
28. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293–302.
29. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502.
30. Kataoka S, Gohbara M, Iwahashi N, Sakamaki K, Nakachi T, Akiyama E, et al. Glycemic variability on continuous glucose monitoring system predicts rapid progression of non-culprit lesions in patients with acute coronary syndrome. Circ J 2015; 79: 2246–2254.
31. Gohbara M, Iwahashi N, Kataoka S, Hayakawa Y, Sakamaki K, Akiyama E, et al. Glycemic variability determined by continuous glucose monitoring system predicts left ventricular remodeling in patients with a first ST-segment elevation myocardial infarction. Circ J 2015; 79: 1092–1099.
32. Mitsuhashi T, Hibi K, Kosuge M, Morita S, Komura N, Kusama I, et al. Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes. JACC Cardiovasc Imaging 2011; 4: 392–401.
33. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: Relationship to insulin resistance. JACC Cardiovasc Imaging 2008; 1: 39–45.
34. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681–1687.
35. Channon KM. Oxidative stress and coronary plaque stability. Arterioscler Thromb Vasc Biol 2002; 22: 1751–1752.
36. Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013; 12: 1.
37. Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: Role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012; 35: 2076–2082.
38. Yamazaki M, Hasegawa G, Majima S, Mitsuhashi K, Fukuda T, Iwase H, et al. Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers. Diabetol Metab Syndr 2014; 6: 54.
39. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Ueyama M, Orii M, et al. Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction. Circ J 2014; 78: 170–179.